Detalhe da pesquisa
1.
High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease.
Liver Int
; 38(8): 1395-1401, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288514
2.
Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis.
J Infect
; 76(6): 536-542, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742470